Announced Wed, 13 May · 16:33 IST

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.8%1-day move
₹894.00
prior close
₹890.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.9+1.6+1.9+1.7+6.8+3.8+4.9+2.3+6.3+1.0-4.1-2.7-9.3
Up moveDown movePending
AI summary

Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received a suspension order for the Drug License of one store located at Basaveshwara Nagar, Karnataka. The suspension is for two days and was issued by the Assistant Director, Drugs Control Administration, Hospet Circle, Vijaynagar, Karnataka. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The order was received on May 12, 2026. The company has disclosed a potential revenue loss of Rs 0.76 lakh due to this suspension.

Likely market impact

This is a minor regulatory event affecting only one store for two days with minimal financial impact of Rs 0.76 lakh. Given the limited scope, it is unlikely to have any significant effect on the company's stock price or operations.